Analysts have nudged their fair value estimate for GoodRx Holdings slightly lower, from about US$4.95 to roughly US$4.56 per ...

Coca-Cola’s story in the market has just been fine tuned, with a small lift in the fair value estimate from about US$77.57 to ...

VIG’s value tilt, cheaper valuation, and stronger dividend growth may shine in a value rotation. Read more macro analysis ...

What Is Driving the New Fair Value Range for Plexus? Plexus now sits in analyst models at a fair value of about US$200.80, up from US$159.00. This figure is supported by updated assumptions around ...

The Angel Oak Financial Strategies Income Term Fund offers a unique portfolio and an impressive yield. Learn more about the ...

Collective defined contribution (CDC) is in the spotlight following the government’s publication of the multi-employer CDC regulations, with the first multi-employer CDC schemes potentially operating ...

The spending and accumulation of Australia’s asset-rich owners is counteracting the belt-tightening of earners – and there’s ...

Analysts have adjusted their price targets for Arq while keeping the fair value anchor steady at 8.625, and only modestly updating assumptions around required returns and long term revenue growth.

The XRP market has returned to focus as technical comparisons and institutional developments converge, while macro signals continue to shape broader risk sentim ...

What are deeming rates?Deeming rates are used to assume the returns people receive on their financial assets that the government applies to Age ...

Meta Platforms continues to be a winner, but gets little respect from the market.

Memory chips are becoming the new bottleneck in AI development.